Sector valuations NovoCure Limited
Equities
NVCR
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.99 USD | -12.29% |
|
+8.38% | -15.00% |
| Feb. 12 | FDA approves first-of-its-kind device to treat pancreatic cancer | RE |
| Feb. 12 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -7.84x | - | 0.77x | - | - | - | - | 1.23B | |
| 78.75x | 9.56x | 0.07x | 9.29x | 55.07x | 69.46x | -.--% | 13.29B | |
| 31.9x | - | -0.19x | - | - | - | - | 6.99B | |
| 21.54x | 1.76x | 0.39x | 1.8x | 9.57x | 14.17x | 2.45% | 6.13B | |
| 19.64x | 2.75x | 2.98x | 3.6x | 13.23x | 14.12x | 1.65% | 5.48B | |
| 39.32x | 10.12x | 1.7x | 12.21x | 30.69x | 34.12x | 0.63% | 4.74B | |
| 24.47x | 4.16x | 0.19x | 4.7x | 14.02x | 16.93x | 1.26% | 4.51B | |
| 42.38x | - | 1.79x | - | - | - | - | 1.66B | |
| -16.84x | 3.61x | 0.7x | 579.79x | -70.17x | -64.2x | -.--% | 1.46B | |
| 22.52x | 1.63x | 3.77x | 2.08x | 8.48x | 11.96x | 2.26% | 1.3B | |
| 31.45x | 2.7x | -1.71x | - | - | - | 0.74% | 1.12B | |
| 31.03x | 8.85x | 1.45x | 11.79x | 20.57x | 23.08x | 1.7% | 1.12B | |
| -29.05x | 3.82x | 0.98x | 2.8x | 91.71x | -21.65x | -.--% | 665M | |
| 33.15x | - | 2.37x | - | - | - | - | 591M | |
| 25.17x | 2.6x | 2.64x | - | - | - | 2.04% | 562M | |
| 34.12x | 2.59x | 0.31x | - | - | - | - | 557M | |
| 22.28x | 1.73x | 0.27x | - | - | - | -.--% | 522M | |
| 15.05x | 4.21x | 0.24x | 4.03x | 10.47x | 10.9x | 0.65% | 498M | |
| Average | 23.28x | 4.29x | 1.04x | 63.21x | 18.36x | 10.89x | 1.03% | 2.91B | |
| Weighted average by Cap. | 38.03x | 5.92x | 0.78x | 28.12x | 27.28x | 32.24x | 0.96% |
- Stock Market
- Equities
- NVCR Stock
- Sector NovoCure Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
